Acyclovir/BW-348U87

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAcyclovir/BW-348U87
Drug Alias NameBW-348U/acyclovir348U87/acyclovirBW-348U87/AcyclovirBW-248U/BW-348UBW-248U/BW-348U87
ClassificationSmall molecules
Mechanisms of ActionRibonucleotide reductase inhibitorsDNA-directed DNA polymerase inhibitors
TargetsDNA-directed DNA polymeraseRibonucleotide reductase
Therapy Area/IndicationsHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes BW-348U87Acyclovir
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A